Regulators, payers and patient advocacy groups want program design to truly reflect patient populations. Phesi is proud to be supporting this mission with the launch of our Digital Patient Profile Catalogue which puts the patient at the heart of drug development.
Developed using Phesi’s Trial Accelerator™ platform with data from more than 60 million patients, our catalogue provides a statistical view of patient attributes such as demographics, diversity, comorbidities, concomitant medications and outcomes for key disease areas including oncology, Alzeheimer’s, Crohn’s disease and ulcerative colitis.
Our Digital Patient Profiles can help you: